2013-11-13T14:47:30-06:00 2012-12-31 KPMG LLP 1676 International Drive McLean VA 22102 990 2012-01-01 237311318 DRUG INFORMATION ASSOCIATION INC % BAYARD G GARDINEER III DRUG 2154426100 800 ENTERPRISE ROAD Suite 200 HORSHAM PA 19044 BAYARD GARDINEER 2154426100 2013-11-08 true 7032868000 2012 2016-02-25 16:41:14Z 27157411 false X WWW.DIAHOME.ORG X 1964 MD ATTACHMENT 1 19 19 101 3137 784954 47314 0 0 29694550 25838696 -17600 1086555 23497 -54353 29700447 26870898 83989 112991 0 0 11989738 11176607 0 0 0 19211157 18379690 31284884 29669288 -1584437 -2798390 20882354 19398220 7594456 9475147 13287898 9923073 X DIA FOSTERS INNOVATION TO IMPROVE HEALTH AND WELL BEING WORLDWIDE BY: PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; DELIVERING CUSTOMIZED LEARNING EXPERIENCES; BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY. false false 8341358 18869606 MEETINGS AND WORKSHOPS DIA PROVIDES A NEUTRAL GLOBAL FORUM FOR THE PURPOSE OF EXCHANGE AND DISSEMINATION OF INFORMATION RELEVANT TO THE PROFESSIONAL EDUCATION AND DEVELOPMENT OF ITS MEMBERS. DIA'S FOCUS IS UNBIASED, PATIENT-CENTRIC TRAINING FOR THE WORLDWIDE MEDICAL COMMUNITY. DIA HAS GROWN TO A GLOBAL LEADERSHIP POSITION IN PROFESSIONAL EDUCATION, BEGINNING WITH TRADITIONAL IN-PERSON EVENTS AND EXPANDING INTO TECHNOLOGY-BASED, ELECTRONIC LEARNING MEDIA. THE NUMBER OF MEETINGS AND WORKSHOPS HELD HAS INCREASED FROM A TOTAL OF TWO EVENTS HELD IN THE UNITED STATES IN 1980, TO A TOTAL OF 398 EVENTS HELD WORLDWIDE IN 2012. IN 2012, DIA CONDUCTED 182 WORKSHOPS AND TRAINING COURSES IN THE UNITED STATES WITH OVER 7,300 PARTICIPANTS. IN ADDITION TO THESE EVENTS, THE DIA ANNUAL MEETING, THE LEADING GLOBAL CONFERENCE ON PHARMACEUTICAL INFORMATION AND EDUCATION, ATTRACTED OVER 6,900 PARTICIPANTS FROM THE US AND ACROSS THE WORLD. IN 2012, DIA CONDUCTED 115 WORKSHOPS AND TRAINING COURSES ACROSS EUROPE, ATTRACTING OVER 3,600 PARTICIPANTS. IN ADDITION, THE ANNUAL DIA EURO MEETING, WHICH ATTRACTED APPROXIMATELY 2,900 PARTICIPANTS, IS RECOGNIZED AS ONE OF THE PREMIER FORUMS FOR EXCHANGE OF INFORMATION IN THE EUROPEAN MEDICAL/PHARMACEUTICAL COMMUNITY. IN 2012, DIA CONDUCTED 11 EDUCATIONAL EVENTS IN JAPAN, ATTRACTING OVER 2,000 PARTICIPANTS FROM JAPAN AND OTHER COUNTRIES. IN 2012 DIA CONDUCTED 13 EDUCATIONAL EVENTS IN INDIA, WITH PARTICIPATION EXCEEDING 1,000 PERSONS. IN 2012, DIA CONDUCTED 12 EVENTS IN CHINA, ATTRACTING OVER 800 PARTICIPANTS. IN ADDITION, DIA CONDUCTED 3 EDUCATIONAL PROGRAM EVENTS IN LATIN AMERICA, WITH PARTICIPATION OF OVER 360 PERSONS. WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS WORKSHOPS IN ELECTRONIC WEBINAR FORMAT. IN 2012, DIA CONDUCTED 60 WEBINARS, ATTRACTING OVER 320 INDIVIDUAL AND GROUP PARTICIPANTS. 1984855 4065496 TRAINING EXPENSES IN 2012 DIA CONDUCTED 182 WORKSHOPS AND TRAINING COURSES IN THE UNITED STATES WITH OVER 7,300 PARTICIPANTS. IN 2012, DIA CONDUCTED 115 WORKSHOPS AND TRAINING COURSES ACROSS EUROPE, ATTRACTING OVER 3,600 PARTICIPANTS. WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS WORKSHOPS IN ELECTRONIC WEBINAR FORMAT. IN 2012 DIA CONDUCTED 60 WEBINARS, ATTRACTING OVER 327 INDIVIDUAL AND GROUP PARTICIPANTS. 559911 944546 PUBLICATIONS FIRST PUBLISHED IN 1969, "DRUG INFORMATION JOURNAL" IS A CAPTIVE SCIENTIFIC PUBLICATION DESIGNED FOR THE BENEFIT OF ASSOCIATION MEMBERS. IT IS PUBLISHED BI-MONTHLY, IN PERIODICAL FORM. ALL ELIGIBLE MEMBERS (APPROX. 18,000) RECEIVE THE PUBLICATION IN ELECTRONIC FORMAT. IN ADDITION, APPROXIMATELY 16,000 MEMBERS RECEIVE A HARD COPY VERSION AS WELL. THE "DRUG INFORMATION JOURNAL" IS RECOGNIZED AS A LEADING SOURCE FOR THE EXCHANGE OF INFORMATION CONCERNING ALL ASPECTS OF DRUG DEVELOPMENT, REGULATION AND UTILIZATION. IT IS REGULARLY INCLUDED IN MANY MAJOR INDICES OF SCIENTIFIC AND MEDICAL LITERATURE. THE "GLOBAL FORUM" IS THE ASSOCIATION'S BI-MONTHLY, 4-COLOR MAGAZINE. THE "GLOBAL FORUM" PRESENTS IMPORTANT NEWS FROM DIA CONFERENCES AND WORKSHOPS, VOLUNTEER REPORTS, REPORTS OF THE BOARD OF DIRECTORS AND REGIONAL ADVISORY COUNCILS THAT DIRECTLY IMPACT DIA MEMBERS AND AS WELL AS PRACTICAL TIPS, REGULATORY AND GLOBAL UPDATES, AND UPCOMING DIA EVENTS. ALL ELIGIBLE MEMBERS RECEIVE BOTH PUBLICATIONS IN ALTERNATING MONTHS THROUGHOUT THE YEAR. 11225488 112991 1962123 22111612 true false false false false false false false false false true false false false true true false true false true true true false false false false false true true true false false false false false false false false false false false false true true true false false false true X 99 0 true 101 true true true true JA IN CH SZ false false false false false false false false X 19 19 false false false false true true true true true false true true true true true true true true true true false X BAYARD G GARDINEER III 2154426126 800 ENTERPRISE RD SUITE 200 HORSHAM PA 19044 X YVES JUILLET 10.0 X X 0 0 0 LING SU 10.0 X X 0 0 0 MINNIE BAYLOR-HENRY 10.0 X X 0 0 0 STEVE CAFFEE 5.0 X 0 0 0 SERGIO GUERRERO 5.0 X 0 0 0 TRUUS JANSE-DE HOOG 5.0 X 0 0 0 TATSUO KUROKAWA 5.0 X 0 0 0 SANDRA L KWEDER 5.0 X 0 0 0 JENNIFER L RIGGINS 5.0 X 0 0 0 JOHN A ROBERTS 10.0 X X 0 0 0 LARISA NAGRA SINGH 5.0 X 0 0 0 PER SPINDLER 5.0 X 0 0 0 BEAT E WIDLER 5.0 X 0 0 0 NING XU 5.0 X 0 0 0 JEAN A YAGER 5.0 X 2450 0 0 MICHELE C LIVESEY 5.0 X 0 0 0 SANDRA A MILLIGAN 5.0 X 0 0 0 DEBORAH DOLAN 5.0 X 0 0 0 JEFFREY W SHERMAN 5.0 X 0 0 0 Frances JRichmond 5.0 X 0 0 0 Gesine Bejeuhr 5.0 X 0 0 0 Nancy Dreyer 5.0 X 0 0 0 Richard Day 5.0 X 0 0 0 Stephen A Sonstein 5.0 X 0 0 0 CHERYL BYRNE 37.5 X 112192 0 20562 CARLOS FULCHER 37.5 X 262475 0 21274 ANDREW PEPITO 37.5 X 165236 0 10792 Paul Pomerantz 37.5 X 588277 0 33413 SUSAN CANTRELL 37.5 X 267199 0 44348 ELIZABETH LINCOLN 37.5 X 154772 0 15690 KO SEKIGUCHI 37.5 X 162425 0 16283 JANE CAI 37.5 X 189845 0 34922 BRIGITTE-FRANKE-BRAY 37.5 X 331447 0 41725 ARULSELVAM SELVARAJ 37.5 X 116685 0 35365 LINDA AMOROSA 37.5 X 144000 0 27100 ALEJANDRO BERMUDEZ DEL VILLAR 37.5 X 130000 0 8237 LORRAINE RISBOSKIN 37.5 X 121663 0 21194 JENNIFER ANDREE-WEBB 37.5 X 122153 0 36474 2870819 0 367379 17 false true false Bella Center Copenhagen CENTER BOULEVARD 5 COPENHAGEN 0 DA 2300 MEETING CONV. CENTER 1796421 Aramark Sports Entertainment Serv 1101 Arch Street PHILADELPHIA PA 19107 Catering Services 643394 Princeton Information Ltd 7-11 Front Street ROCKVILLE CENTER NY 11570 IT CONSULTING SVCS 338451 Fierce Markets Inc 1900 L Street Ste 400 WASHINGTON DC 20004 Advertising Services 220032 Pennsylvannia Convention ctr author 1101 Arch Street PHILADELPHIA PA 19107 meeting conv. center 218713 27 0 MEETINGS AND WORKSHOPS 611710 18869606 18869606 TRAINING 611710 4065496 4065496 PUBLICATIONS 900004 944546 159592 784954 MEMBERSHIP DUES 900099 1959048 1959048 25838696 1099135 1099135 0 0 131681 189109 -57428 0 -57428 -57428 84824 97404 -12580 -12580 -12580 0 0 0 OTHER INCOME 900099 3075 3075 3075 26870898 25056817 784954 1029127 65000 65000 12991 12991 35000 35000 0 3011987 1867432 1144555 0 5746638 3562916 2183722 687550 426281 261269 1050475 651294 399181 679957 421574 258383 179595 77424 102171 225664 47166 178498 112181 112181 0 0 0 0 787346 787346 213921 132569 81352 631470 372543 258927 0 524158 446406 77752 1098922 680994 417928 892 892 87178 87178 0 0 478690 296787 181903 144504 89593 54911 MEETING AND WORKSHOP EXPENSE 8350358 8350358 TRAINING EXPENSE 2006872 2006872 CONSULTING EXPENSES 1045200 912386 132814 MEMBERSHIP DEVELOPMENT 587234 587234 1905505 1067900 837605 29669288 22111612 7557676 0 X 0 0 1366854 1720754 0 0 262119 332030 0 0 0 0 0 0 0 0 1544519 1214138 10685143 4278534 6615385 6406609 10731248 9604482 0 0 0 0 0 0 362229 120207 20882354 19398220 2351937 2984769 0 0 5236085 4983944 0 0 0 0 0 0 0 0 0 1500000 6434 6434 7594456 9475147 X 13287898 9923073 0 0 0 0 13287898 9923073 20882354 19398220 X -2798390 -566435 X false true X true false X 2222937 2258742 2162718 2136971 1959048 10740416 27751063 26063903 24287432 26478746 23066783 127647927 0 0 0 29974000 28322645 26450150 28615717 25025831 138388343 0 0 0 138388343 680364 1883998 1495316 0 1099135 5158813 0 680364 1883998 1495316 0 1099135 5158813 0 275000 4738 2136 3075 284949 30654364 30481643 27950204 28617853 26128041 143832105 0.96215 0.96170 0.03587 0.03640 X 2589372 2589372 5608939 2150807 3458132 118778 102816 15962 1929139 1660002 269137 438915 364909 74006 6406609 0 SECURITY DEPOSIT PAYABLE 6434 6434 29300468 2416990 2416990 26883478 -12580 -12580 26870898 32665293 2983425 2983425 29681868 -12580 -12580 29669288 SCHEDULE D, PART X SHOULD SETTLEMENT OF AN EXAMINATION OR OTHER EVENT RESULT IN A CHANGES IN MANAGEMENT'S EVALUATION OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN FILINGS THAT HAVE NOT BEEN CLOSED BY STATUE OR EXAMINATION, ANY ADDITIONAL INTEREST AND PENALTIES RELATED TO THE UNRECOGNIZED TAX BENEFIT AS A RESULT OF THE UNCERTAIN TAX POSITION WILL BE INCLUDED IN OPERATING EXPENSES. SCHEDULE D, PART XI, LINE 2D SUBSIDIARIES REVENUE 2,227,881 RENTAL EXPENSES 189,109 ------------ TOTAL 2,416,990 SCHEDULE D, PART XI, LINE 4B LOSS ON SALE OF EQUIPMENT (12,580) SCHEDULE D, PART XII, LINE 2D SUBSIDIARIES EXPENSE 2,794,316 RENTAL EXPENSES 189,109 ------------ TOTAL 2,983,425 SCHEDULE D, PART XII, LINE 4B LOSS ON SALE OF EQUIPMENT (12,580) true Europe (Including Iceland and Greenland) 1 29 Program Services Workshops & Training 8386961 South Asia 1 6 Program Services Workshops & Training 278154 South Asia 1 8 Program Services Workshops & Training 1593593 South Asia 1 6 Program Services Workshops & Training 1422573 4 49 4 49 11681281 11681281 South America FUNDING FOR THE ORGANIZATION 10000 WIRE TRSF Europe (Including Iceland and Greenland) 5TH GLOBAL PATIENT CONGRESS MULT BEHAVIOURS OF CANCER PATIENTS IN AMBULATORY HEALTH CARE SETTINGS 25000 WIRE TRSF 1 true false true false false true FORM 990, SCHEDULE F, PART 1 DEPENDING ON THE USE OF FUNDS (E.G. EDUCATIONAL PROGRAMS, RESEARCH, MEETING ATTENDANCE, ETC.), EACH GRANTEE IS REQUIRED TO REPORT TO DIA MANAGEMENT, ON A REGULAR SCHEDULE, THE FOLLOWING: DETAILED PROGRAM CONTENT DOCUMENTS; NUMBER OF PARTICIPANTS; ONGOING RELEVANCE OF SUBJECT MATTER TO DIA'S MISSION; ACTUAL VS. PROPOSED TIMELINE; PROOF OF BUDGETARY ALLOCATION TO TIMELINE; REVISED TIMELINE FOR GRANT CYCLE; PROJECTED OUTCOME OF PROJECT; AND A FINAL REPORT ON THE OUTCOME OF THE PROJECT. true Alstrom Syndrome International 14 Whitney Farm Road PO BOX 1450 MOUNT DESERT ME 04660 010515187 501(C)(3) 10000 To fund the The alstrom syndrome Handbook DESIGNATED ORPHAN PRODUCTS Arthritis Foundation 122 East 42nd street SUITE 800 NEW YORK NY 10168 800489313 501(C)(3) 15000 To develop Arthritis & specific joints regional we SYMPOSIUM SYNDROMES WITHOUT A NAME USA 1745 LORNA LANE ST OTSEGO MI 49078 134360128 501(C)(3) 25000 Funding for programs DESIGNATED ORPHAN PRODUCTS Parkinson's Disease Foundation 1359 Broadway NEW YORK NY 10018 131866796 501(C)(3) 15000 To fund the Clinical research learn inst 4 4 GRANTS TO SPEAKERS 30 12991 FMV SCHEDULE I, PART 1, LINE 2 DEPENDING ON THE USE OF FUNDS (E.G. EDUCATIONAL PROGRAMS, RESEARCH, MEETING attendance, etc.), each grantee is required to report to DIA management, on a regular schedule, the following: detailed program content documents; number of participants; ongoing relevance of subject matter to DIA's mission; actual vs. proposed timeline; proof of budgetary allocation to timeline; revised timeline for grant cycle; projected outcome of project; and a final report on the outcome of the project. X X X X false false false false false false false false false ARULSELVAM SELVARAJ 107100 0 9585 0 0 0 10503 0 24862 0 152050 0 0 0 LINDA AMOROSA 140000 0 4000 0 0 0 14120 0 12980 0 171100 0 0 0 CARLOS FULCHER 227766 0 34709 0 0 0 19510 0 1764 0 283749 0 0 0 ANDREW PEPITO 132399 0 32837 0 0 0 8747 0 2045 0 176028 0 0 0 SUSAN CANTRELL 252370 0 14829 0 0 0 24968 0 19380 0 311547 0 0 0 JENNIFER ANDREE-WEBB 112500 0 9653 0 0 0 11582 0 24892 0 158627 0 0 0 ELIZABETH LINCOLN 131950 0 22822 0 0 0 14148 0 1542 0 170462 0 0 0 KO SEKIGUCHI 147356 0 15069 0 0 0 7653 0 8630 0 178708 0 0 0 JANE CAI 169505 0 20340 0 0 0 15800 0 19122 0 224767 0 0 0 BRIGITTE-FRANKE-BRAY 298961 0 32486 0 0 0 35620 0 6105 0 373172 0 0 0 Paul Pomerantz 399885 0 188392 0 0 0 23412 0 10001 0 621690 0 0 0 FORM 990- PART III LINE 4D PROGRAM SERVICE THE ASSOCIATION MAINTAINS A PHILANTHROPY COMMITTEE THAT SERVES AS A VEHICLE OF SUPPORT FOR ONGOING STUDY OF DRUG DEVELOPMENT. THE COMMITTEE RECEIVES GRANT PROPOSALS AND OTHER REQUESTS, EVALUATES THEM AND AWARDS GRANTS, FELLOWSHIPS AND OTHER SUPPORT USED TO TRAIN QUALIFIED SCIENTISTS IN CLINICAL PHARMACOLOGY, PHARMACO EPIDEMIOLOGY, DRUG EVALUATION, AND DRUG REGULATION. A GRANT PROGRAM ALSO EXISTS TO ADVANCE THE STUDY OF DRUG INFORMATION IN ACADEMIC INSTITUTIONS. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS MEMBERS WHO PAY DUES BUT HAVE NO OWNERSHIP INTEREST IN THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 7A EACH MEMBER IS ENTITLED TO ONE VOTE TO ELECT DIRECTORS, ONE VOTE TO ELECT OFFICERS AND ONE VOTE TO CHANGE THE BY-LAWS OF THE ORGANIZATION. SERVICE AS OFFICER AND/OR BOARD DIRECTOR IS ON A VOLUNTEER BASIS. FORM 990, PART VI, SECTION A, LINE 7B EACH MEMBER OF THE BOARD (THE GOVERNING BODY) IS DULY ELECTED BY A PROXY VOTE OF THE MEMBERSHIP. THE ORGANIZATION'S BY-LAWS DEFINE THE DUTIES, RESPONSIBILITIES AND POWERS OF THE BOARD, INCLUDING THOSE ACTIONS SUBJECT TO MEMBERSHIP APPROVAL. FORM 990, PART VI, SECTION B, LINE 11A THE DRAFT 990 IS REVIEWED JOINTLY BY THE EXECUTIVE DIRECTOR, THE CFO AND THE FINANCE COMMITTEE CHAIR. AFTER THIS REVIEW IS COMPLETE, A COPY OF THE FINAL RETURN IS PROVIDED TO EACH SITTING BOARD MEMBER. AFTER EACH BOARD MEMBER RECEIVES A FINISHED COPY, THE COMPLETE RETURN IS FILED. FORM 990, PART VI, SECTION B, LINE 12C PERIODICALLY MANAGEMENT EVALUATES ALL EXISTING PAID VENDOR RELATIONSHIPS FOR GOODS AND/OR SERVICES. THEY ASSESS THE PARTIES INVOLVED AND THE RELATIONSHIPS BETWEEN THEM AND DIA. WHERE CONFLICTS WITH STANDING POLICY MAY DEVELOP OR EXIST, APPROPRIATE CORRECTIVE ACTIONS ARE TAKEN, UP TO AND INCLUDING REPLACEMENT OF THE VENDOR WITH A SUITABLE AND QUALIFIED SUBSTITUTE THAT POSES NO CONFLICT OF INTEREST. NEW VENDORS ARE EVALUATED TO DETERMINE IF POTENTIAL CONFLICTS EXIST BEFORE APPROVAL OF ANY PAID RELATIONSHIP IS GRANTED. FORM 990, PART VI, SECTION B, LINE 15A & 15B ON A REGULAR BASIS, BUT NO LESS THAN BIENNIALLY, THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE COMPLETE COMPENSATION PACKAGES OF ALL KEY EMPLOYEES TO ENSURE THEY ARE COMPLIANT WITH ALL APPLICABLE LAWS AND CONSISTENT WITH THE PROVISIONS OF STANDING COMPENSATION POLICY. THIS INCLUDES SALARY, BENEFITS, BONUSES AND OTHER PAYMENTS MADE TO BOTH SENIOR MANAGEMENT AND ALL OTHERS DEEMED TO BE SUBJECT TO COMPENSATION REVIEW. THE RESULTS OF THE EVALUATION ARE PRESENTED TO THE BOARD OF DIRECTORS IN A FORMAL, WRITTEN COMPENSATION REPORT. FORM 990, PART VI, SECTION C, LINE 19 DIA'S FORM 990 AND FORM 990-T ARE AVAILABLE UPON REQUEST. THE FORM 990 IS ALSO AVAILABLE ON GUIDESTAR.COM. THE ORGANIZATION'S BYLAWS ARE AVAILABLE TO THE PUBLIC ON ITS WEBSITE. CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART XI, LINE 9 SUBSIDIARY REVENUE $ 2,227,881 SUBSIDIARY EXPENSES $(2,715,776) ----------- TOTAL $ (566,435) =========== DRUG INFORMATION ASSOCIATION LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 DRUG EDUCATIO PA 712512 55285 DIA DIA GLOBAL HEALTHCARE LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 DRUG EDUCATIO PA 10 10049 DIA DIA (INDIA) PRIVATE LIMITED A303 ANDHERI KURLA RD MAROL ANDHERI MUMBAI India IN 400 059 DRUG RESEARCH IN DIA INC PRIVATE LC 202159 42289 1.00000 DIA EUROPE GMBH ELISABETHENANLAGE 25 POSTFACH BASEL SZ 4002 DRUG RESEARCH SZ DIA INC LLC 62 245650 1.00000 DIA E-LEARNING EUROPE GMBH ELISABETHENANLAGE 25 POSTFACH BASEL SZ 4002 E-EDUCATION SZ DIA INC LLC 8 20811 1.00000 DIA (BEIJING) HEALTHCARE INFORMATION GATEWAY PLAZA BEIJING CH DRUG EDUCATIO CH DIA GLOBAL PRIVATE LLC 1244151 130841 1.00000 SH DIA Japan Nisso 22 Bldg 7F Minato-Ku Tokyo JA DRUG RESEARCH JA dia llc GIC 668934 100953 1.00000 false true false false false false false false false false false true true true false true false true true DIA(INDIA) PRIVATE LIMITED B 114700 FMV